Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T04:15:51.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Major update: expanded immune biology terminology and a version upgrade to v3.1.0, replacing v3.0.2.
    Difference
    0.9%
    Check dated 2025-09-28T23:37:18.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, replacing v3.0.1. The Back to Top link has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:41:49.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T07:15:12.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has added significant medical terms related to antibodies and proteins, as well as a new facility name and location, while removing various cancer-related terms and location details.
    Difference
    4%
    Check dated 2025-08-31T00:52:45.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T20:02:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.